Jun Chen

5PUBLICATIONS
28CO-AUTHORS
Reaction kinetics and dynamicsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 13, 2026
Clinicopathological Evolution of Pyrrolizidine Alkaloid-induced Liver Injury: Transition From SOS to PSVD?

|May 04, 2026
IGF2BP2 Overexpression Predicts Poor Prognosis and Correlates with PD-L1 Expression in Intrahepatic Cholangiocarcinoma.

|Dec 01, 2025
Tislelizumab and Hypofractionated Radiotherapy plus Nab-Paclitaxel/Gemcitabine as Conversion Therapy for BRPC/LAPC: A Phase II Trial with Dynamic Biomarker Monitoring.

Jiayao Ni, Yi Sun, Hao Cheng

|Oct 30, 2025
FXYD3 Promotes Tumor Progression by Binding With IRF7 to Regulate JAK2/STAT5 Signaling in Intrahepatic Cholangiocarcinoma.

Yan Zhou, Xiaofeng Shen, Shuo Zhang

|Nov 15, 2023
Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomas.

Xiaohong Pu, Liang Qi, Jia Wu Yan

Pageof 1

Frequent Collaborators

1 joint publications

Yan Zhou

1 joint publications

Yihang Yuan

1 joint publications

Jiayao Ni

1 joint publications

Yi Sun